Explore the latest books of this year!
Bookbot

Drugs and the Pharmaceutical Sciences - 143: Generic Drug Product Development

Solid Oral Dosage Forms

Parameters

  • 381 pages
  • 14 hours of reading

More about the book

Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of generic drug products including the availability of raw materials, chemical purity. It also highlights constraints in generic drug development that differ from the formulation design of a brand name pharmaceutical product.

Book purchase

Drugs and the Pharmaceutical Sciences - 143: Generic Drug Product Development, Leon Shargel, Isadore Kanfer

Language
Released
2004
product-detail.submit-box.info.binding
(Hardcover),
Book condition
Damaged
Price
€38.57

Payment methods

No one has rated yet.Add rating

Title
Drugs and the Pharmaceutical Sciences - 143: Generic Drug Product Development
Subtitle
Solid Oral Dosage Forms
Language
English
Publisher
CRC Press
Released
2004
Format
Hardcover
Pages
381
ISBN10
0824754603
ISBN13
9780824754600
Series
Description
Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of generic drug products including the availability of raw materials, chemical purity. It also highlights constraints in generic drug development that differ from the formulation design of a brand name pharmaceutical product.